Related Experiment Video
Updated: May 5, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Enhancement of the Mayo Clinic HCM Genotype Predictor Score with Addition of Cardiac Magnetic Resonance Imaging
Iuri Ferreira Felix1, Vanessa Karlinski Vizentin2, Mateo Alzate-Aguirre2
1Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Insights
Cardiac magnetic resonance (CMR) enhances the Hypertrophic Cardiomyopathy (HCM) Genotype Predictor Score. Adding late gadolinium enhancement (LGE) to the score significantly improves genetic testing accuracy in HCM patients.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition.
- Genetic testing is crucial for HCM diagnosis and risk stratification.
- The Mayo Clinic Hypertrophic Cardiomyopathy Genotype Predictor Score aids genetic testing.
Purpose of the Study:
- To evaluate the role of cardiac magnetic resonance (CMR) in updating the Mayo Clinic HCM Genotype Predictor Score.
- To assess if incorporating CMR findings improves the score's accuracy in predicting positive genetic test results.
Main Methods:
- Analysis of 175 HCM patients with echocardiogram, CMR, and genetic test data (2004-2018).
- Comparison of the original echocardiogram-based score with an updated score including late gadolinium enhancement (LGE) on CMR.
- Statistical analysis to determine the predictive value and diagnostic accuracy of both scores.
Main Results:
- The original score showed a positive genetic test yield from 38% to 100% (AUC 0.659).
- Late gadolinium enhancement (LGE) on CMR was a significant predictor of positive genetic results (p=0.002).
- The updated score, including LGE, demonstrated improved yield (25% to 100%, p<0.001) and AUC (0.724), with increased diagnostic accuracy (p=0.03).
Conclusions:
- Cardiac magnetic resonance (CMR) findings, specifically late gadolinium enhancement (LGE), significantly improve the accuracy of the Hypertrophic Cardiomyopathy (HCM) Genotype Predictor Score.
- The updated score offers enhanced diagnostic utility for genetic testing in HCM patients.
- CMR integration represents a valuable advancement in HCM genetic risk assessment.
Abstract:
This study aimed to evaluate the role of cardiac magnetic resonance (CMR) in updating The Mayo Clinic Hypertrophic Cardiomyopathy (HCM) Genotype Predictor Score. We performed an analysis of 175 HCM patients with an echocardiogram, CMR, and genetic test at the Mayo Clinic (2004 to 2018). Yield of a positive genetic test for the original echocardiogram-based score ranged from 38% (-1 point) to 100% (4 or 5 points), with an AUC of 0.659. Late gadolinium enhancement (LGE) presence was a strong predictor of positive genetic test (p = 0.002) and was added to the original score to create the updated version. The yield of positive genetic test for the updated score ranged from 25% (-1 point) to 100% (5 or 6 points) (p < 0.001), with an AUC of 0.724 and significant increase in diagnostic accuracy (p = 0.03). The updated genotype predictor score had improved accuracy when compared to the prior version.
More Related Videos
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care